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Bartonella Species
Isolated from
Rodents, Greece
To the Editor: Domestic cats and
human body lice have been identified
as the vectors of Bartonella henselae
and B. quintana, respectively, the pri-
mary sources of Bartonella-associat-
ed human diseases (1). Bartonella
species are zoonotic agents that have
been isolated from a wide range of
mammals in the United States (2) and
Europe (3) and have been associated
with human diseases (4–5). 
This study investigated the poten-
tial for infection from Bartonella
species in rodents in northern Greece.
The small mammals tested were col-
lected with live traps (6). Two sites
were surveyed; the first was
Nevrokopi, a small town in the
Rhodope Mountains near the Greek-
Bulgarian border, and the second site
included Pramanta, a small village in
the Pindos Mountains, and Matsuki, a
small village in northwestern Greece.
At Nevrokopi, 57 small mammals
were captured during 887 trap nights
for a success rate of 6.4%. At
Pramanta and Matsuki, 13 small
mammals were captured during 400
trap nights for a success rate of 3.3%.
The 70 captured mammals comprised
seven species of rodents. Apodemus
flavicollis was the most commonly
captured species (87%). Blood sam-
ples from each of the trapped mam-
mals were frozen in liquid nitrogen in
the field and subsequently stored at
–70ºC before bacteria isolation.
Bacteria isolation was performed as
previously described (7). One hun-
dred microliters of whole mammalian
blood was cultured on heart infusion
agar containing 5% rabbit blood
(Becton Dickinson, Franklin Lakes,
NJ) and incubated in 5% CO2 at 35°C
for a minimum of 4 weeks. DNA of
the putative Bartonella cultures was
extracted by using QIAamp Tissue
Kit (Qiagen GmbH, Hilden,
Germany). Polymerase chain reaction
(PCR) was performed by using two
oligonucleotides specific for the cit-
rate synthase (gltA) gene of B. hense-
lae Houston 1, primers BhCS 781.p
and BhCS 1137.n. Negative and posi-
tive controls (double-distilled H2O
and DNA from cultures of B. hense-
lae) were used in each PCR run.
Products of the correct size were puri-
fied (QIAquick PCR Purification kit,
Qiagen GmbH) and sequenced with
the same primers, BhCS 781.p and
BhCS1137.n., in both directions, with
the Cy5/Cy5.5 Dye Primer Cycle
Sequencing kit on a Long-Read
Tower sequencer (Visible Genetics
Inc., Toronto, Canada). Three hundred
thirty-eight base-pair sequences of the
gltA gene were obtained and com-
pared with sequences of other known
Bartonella species in GenBank by
using the nucleotide BLAST program
(National Center for Biotechnology
Information; Available from:
www.ncbi.nlm.nih.gov/BLAST/).
Isolates identified as Bartonella
species were obtained from 21 of the
70 blood cultures. All were isolated
from A. flavicollis, and one was isolat-
ed from Dryomys nitedula. In addi-
tion, all were isolated from the first
site (Nevrokopi village), and one was
isolated from the second site
(Pramanta village).
Within these 21 Bartonella  iso-
lates, eight genotypes were found.
Among these isolates, one (AY435102
isolated from A. flavicollis trapped in
Pramanta), was identical to ma106up
strain, isolated from Microtus agresti
(AF391789); another (AY435103 iso-
lated from A. flavicollis trapped in
Nevrokopi), was identical to af82up
strain (AF391788), also isolated from
A. flavicollis (3). Both strains
ma106up (AF391789) and af82up
(AF391788) were isolated in central
Sweden (3) The rest of Bartonella iso-
lates were from mammals trapped in
Nevrokopi village and were divided
into three phylogenetic groups. The
first group, containing 10 isolates
(AY435104–AY435113, isolated from
A. flavicollis) and representing four
novel genotypes, was 98% similar to
B. taylorii (AF191502, isolated from
A. sylvaticus) gltA gene. The second
group, consisting of seven isolates that
shared the same genotype (AY435114-
AY435120 isolated from A. flavicol-
lis), was 99% similar to B. birtlesii
(AF204272 isolated from Apodemus
spp.). The third group consisted of two
isolates that shared the same genotype
(AY435121 isolated from D. nitedula,
and AY435122 isolated from A. flavi-
collis); this group was 97% similar to
B. grahamii strain V2 (Z70016 isolat-
ed from Neomys fodiens).
This is the first study to identify
Bartonella in small mammals in
Greece. We found that 31.3% of the
examined mammals were infected
with Bartonella spp. The prevalence
of culture-positive infections differed
between the two sites (20/57 versus
1/13), although both are mountain
areas with similar environmental and
climatic conditions. Ahigh prevalence
of Bartonella infection in small mam-
mals also has been described in other
countries such as the United States (7)
and Sweden (3), where 42.2% and
16.5% of the collected rodents were
infected with Bartonella spp., respec-
tively. As indicated in these studies,
numerous  Bartonella species are
found in rodents. A. flavicollis was the
most commonly captured species in
Sweden (110/236), as well as in
Greece (61/70). Identical Bartonella
strains were isolated from A. flavicol-
lis and Microtus agresti in both coun-
tries. Unlike Sweden, where the most
frequent genotype was B. grahamii, in
this study no isolate was identical to
any  Bartonella species known to
cause human diseases. However,  B.
elizabethae was first isolated from a
patient with endocarditis, and nothing
was known concerning the organism’s
natural history until it was isolated
from a rodent captured in Peru (4).
The occurrence and distribution of
Bartonella in European hosts are
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largely unknown. Given the existence
of Bartonella spp. in every mammal
group examined to date, the diversity
of the genus is probably much greater
than has been observed among the
strains examined to date. In Greece,
serologic evidence of human infection
with B. henselae and B. quintana (8),
has been found and a case of B. quin-
tana endocarditis has been established
(unpub. data). The public health rele-
vance of Bartonella infections in
small mammals in Greece compared
with other countries remains to be
defined.
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Reemerging Murine
Typhus, Japan
To the Editor: Murine typhus is
an arthropod-borne infectious disease
caused by Rickettsia typhi, which is
distributed widely around the world
(1–4). In Japan, tsutsugamushi dis-
ease occurs most frequently in per-
sons infected with rickettsioses (5).
Spotted fever caused by R. japonica
also occurs in the southwestern part of
Japan (6,7). In the 1940s and 1950s,
many murine typhus cases were
reported in Japan. These diagnoses
were made according to the clinical
features of the illness and the reactiv-
ity of the serum samples to OX19 in
Weil-Felix tests. A few cases were
diagnosed on the basis of symptoms
exhibited by animals infected with
isolated rickettsiae and complement
fixation tests, in addition to results of
the Weil-Felix tests. The Weil-Felix
test is useful for preliminary screen-
ing of rickettsiosis; however, the reac-
tion could indicate epidemic typhus or
spotted fever in some cases. Since
1958, only three murine typhus cases
have been reported in Japan (8). In
these cases, no serologic tests for epi-
demic typhus were conducted. Serum
sample from patients with epidemic
typhus and murine typhus frequently
possess serologic cross-reactivity to
R. typhi and R. prowazekii, respective-
ly (9). Thus, the possibility of epidem-
ic typhus could not be excluded defin-
itively in these cases. 
On May 4, 2003, a 56-year-old
man living in Tokushima, Japan,
sought medical care; he had a temper-
ature of 39.1°C and exanthema on the
trunk and the upper limbs. No surface
lymph nodes were palpable. He was
treated with lincomycin and cefdi-
toren pivoxil with no improvement.
On day 3, the patient informed care-
givers that he had been in a bamboo
grove on days 1 and 11 before the
onset of symptoms. C-reactive protein
of the serum sample collected on day
3 was positive (= 7.6 mg/dL). From
this finding, spotted fever was sus-
pected; the disease is endemic in
Tokushima. On day 4, the exanthema
had spread systemically, and treat-
ment with minocycline was started,
which led to a gradual decrease in
fever and rashes. The patient was
admitted to the Tokushima University
Hospital on day 6 of the illness for
diagnosis and further treatment. 
Serum samples were collected
from the patient on days 5, 6, 9, 20,
and 34. Indirect immunoperoxidase
tests on the serum samples for tsut-
sugamushi disease, spotted fever,
murine typhus, and Q fever on day 5
of the illness were negative for
immunoglobulin (Ig) G and IgM anti-
bodies (<1:40). Weil-Felix tests on the
serum samples on days 5 and 9 of the
illness were negative for OX2, OX19,
and OXK. Indirect immunofluores-
cence of the serum samples on days 6,
9, 20, and 34 of the illness was con-
ducted by using strains 18 and
Wilmington of R. typhi, and the strain
Breinl of  R. prowazekii as typhus
group rickettsiae; and the strain YH of
R. japonica, the strain Malish 7 of R.
conorii, and the strain Tick of R. mon-
tanensis as the spotted fever group
rickettsiae. All serum samples tested
for the rickettsiae showed an IgM titer
of 1:20. On the other hand, the IgM
titers of these serum samples, to the
Orientia tsutsugamushi were  <1:20.
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